| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Formela Jean Francois is a Director at SPRO, with reported holdings spanning 4 companies. Recent filings cover 2 purchases and 63 sales. Those positions are worth an estimated $11.4M at current prices.
Our model assigns Formela Jean Francois a strong insider score of 70/100, based on 12 past trades. Over a 12-month horizon, 91.7% of those trades were profitable, with an average 12-month return of +42.4%.
Formela Jean Francois's largest disclosed position is in IMA as Director, worth about $7.0M. Net of sales, the recent Form 4 record there shows accumulation of 98,722 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | KRRO Korro Bio, Inc. | Director | Sell | 110,023 | $14.02 | $1,542,970.08 | -6.0% | - | - | |
| Jun 24, 2026 | KRRO Korro Bio, Inc. | Director | Sell | 171,405 | $14.34 | $2,458,582.35 | -4.0% | - | - | |
| May 28, 2026 | KRRO Korro Bio, Inc. | Director | Sell | 2,860 | $13.95 | $39,897.00 | -0.3% | - | - | |
| Dec 14, 2021 | IMA Imagenebio, Inc. | Director | Sell | 26,278 | $14.67 | $385,571.87 | -0.7% | -59.2% | -80.1% | |
| Jun 28, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 553,376 | $132.73 | $73,448,878.91 | -13.8% | +10.6% | -61.0% | |
| Jun 14, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 201,725 | $87.04 | $17,558,773.95 | -4.2% | +75.4% | -56.3% | |
| Apr 29, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 4,513 | $85.43 | $385,545.59 | -0.6% | +70.0% | -38.8% | |
| Apr 28, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 342,962 | $85.96 | $29,482,338.40 | -5.8% | +55.2% | -41.1% | |
| Apr 5, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 800 | $84.98 | $67,984.00 | - | +86.3% | -12.6% | |
| Mar 30, 2021 | IMA Imagenebio, Inc. | Director | Buy | 125,000 | $16.00 | $2,000,000.00 | +16.7% | -44.1% | -76.1% |